Bob is an accomplished biopharmaceutical executive with over thirty years’ experience in a variety of alliance management, business development, commercial, corporate, and research and development roles. Bob is responsible for leading Pfizer’s Global Gene Therapy Business including the strategic and operational development and implementation of Pfizer’s enterprise-wide efforts to be an industry leader in gene therapy.
Prior his current role, Bob was responsible for leading and managing the Worldwide Business Development activities for Pfizer’s Worldwide Research and Development organization as well as Pfizer’s Strategic Transactions team. During his tenure at Pfizer, Bob also had responsibility for leading and managing the business development teams for Pfizer’s Animal Health, Capsugel, Consumer Healthcare and Nutrition Business Units and the Alliance Management function supporting Pfizer’s Biopharmaceutical Business Units and the Worldwide Research and Development organization.
Bob joined Pfizer from Wyeth in October 2009, following Pfizer’s acquisition of Wyeth, where he was responsible for leading and managing Wyeth’s Global Mergers and Acquisitions group. He was also responsible for the global mergers and acquisitions activities for Wyeth’s Consumer Healthcare division and its Fort Dodge Animal Health division. Prior to this role, Bob was Senior Vice President, Global Licensing, Wyeth Pharmaceuticals, where he completed a wide variety of transactions in support of Wyeth’s commercial and research and development divisions.
Bob serves a member of the Board of Directors of AM Pharma B.V. (Observer), Bamboo Therapeutics Inc. (acquired by Pfizer in August 2016), Ignite Immunotherapeutics Inc., Iterum Therapeutics Limited (Observer), Life Sciences PA – the Pennsylvania Biotechnology Association and the Alliance for Regenerative Medicine.
Bob obtained a B.S. in Neuroscience from the University of Rochester and an M.B.A. in Finance and Corporate Accounting from the William E. Simon Graduate School of Business Administration at the University of Rochester, Rochester, New York.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.